Trademark: 88777788
Status Date
Tuesday, May 31, 2022
Registration Number
6741924
Registration Date
Tuesday, May 31, 2022
Filing Date
Wednesday, January 29, 2020
Published for Opposition
Tuesday, March 15, 2022
5 Clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
1 Biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders, for diagnosis and treatment of sepsis
44 Medical services; medical pathology services; medical pathology services being the analysis of body fluid samples; medical services being molecular diagnostic services and taking of body fluid samples of others; providing information, advisory and consultancy services in relation to medical services, medical pathology services, the analysis of body fluid samples, medical services being molecular diagnostic services and taking of body fluid samples of others
10 Surgical and medical apparatus and instruments for use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; peripheral blood or immune cell diagnostic test apparatus for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; diagnostic testing kits in this class consisting primarily of probes, buffers and reagents for use in microbial testing; point of care medical devices, namely, devices using nucleic acid amplification in the nature of real-time polymerase chain reaction or isothermal amplification, DNA sequencing or analyte quantification in the nature of mass spectrometry, protein array for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
May 31, 2022
Notice Of Registration Confirmation Emailed
May 31, 2022
Registered-Principal Register
Mar 15, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 15, 2022
Published For Opposition
Feb 23, 2022
Notification Of Notice Of Publication E-Mailed
Feb 8, 2022
Case Returned To Examination
Feb 8, 2022
Notice Of Allowance Cancelled
Feb 7, 2022
Attorney Review/Decision On Amendment Required
Feb 7, 2022
Petition To Director - Change Basis - Granted
Feb 3, 2022
Assigned To Petition Staff
Jan 21, 2022
Teas Petition To Amend Basis Received
Dec 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2021
Sou Extension 2 Granted
Dec 8, 2021
Sou Extension 2 Filed
Dec 8, 2021
Teas Extension Received
Jun 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 8, 2021
Sou Extension 1 Granted
Jun 8, 2021
Sou Extension 1 Filed
Jun 8, 2021
Teas Extension Received
Dec 8, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 13, 2020
Official Gazette Publication Confirmation E-Mailed
Oct 13, 2020
Published For Opposition
Sep 23, 2020
Notification Of Notice Of Publication E-Mailed
Sep 7, 2020
Approved For Pub - Principal Register
Sep 7, 2020
Examiner's Amendment Entered
Sep 7, 2020
Notification Of Examiners Amendment E-Mailed
Sep 7, 2020
Examiners Amendment E-Mailed
Sep 7, 2020
Examiners Amendment -Written
Apr 17, 2020
Notification Of Non-Final Action E-Mailed
Apr 17, 2020
Non-Final Action E-Mailed
Apr 17, 2020
Non-Final Action Written
Apr 17, 2020
Assigned To Examiner
Feb 12, 2020
Preliminary/Voluntary Amendment - Entered
Feb 12, 2020
Assigned To Lie
Feb 7, 2020
Assigned To Lie
Feb 3, 2020
Teas Voluntary Amendment Received
Feb 4, 2020
New Application Office Supplied Data Entered In Tram
Feb 1, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
